Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2171771 | 1.00 | HCAR2 (0.41) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL11749041 | 0.87 | HCAR2 (0.52) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL11748372 | 0.87 | HCAR2 (0.52) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL15355366 | 0.87 | HCAR2 (0.52) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL15855932 | 0.84 | HCAR2 (0.34) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL15855933 | 0.84 | HCAR2 (0.34) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL15855936 | 0.81 | HCAR2 (0.41) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL15855935 | 0.81 | HCAR2 (0.41) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL13282549 | 0.80 | — | — | |
| SCHEMBL690461 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030068295-A1 | Odor neutralizers | SYMRISE AG (DE) | 2003-04-10 | — | — | US | claimed |
| EP-1239890-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2002-09-18 | — | — | EP | claimed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | claimed |
| EP-3661567-A1 | SCENT SWITCH DEVICE | Symrise AG (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-20200171194-A1 | SCENT SWITCH DEVICE | SYMRISE AG (DE) | 2020-06-04 | — | — | US | disclosed |
| WO-2019025007-A1 | SCENT SWITCH DEVICE | SYMRISE AG (DE) | 2019-02-07 | — | — | WO | disclosed |
| EP-2346535-A1 | MALODOR CONTROL SYSTEM | The Procter & Gamble Company (US) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010053891-A1 | MALODOR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20100111889-A1 | Malodor Control System | PROCTER & GAMBLE COMPANY, THE | 2010-05-06 | — | — | US | disclosed |
| US-7157411-B2 | Odor neutralizers | SYMRISE GMBH & CO. KG (DE) | 2007-01-02 | — | — | US | disclosed |
| EP-1239890-B1 | ODOR NEUTRALIZERS | SYMRISE GMBH & CO KG (DE) | 2004-11-10 | — | — | EP | disclosed |
| US-20030068295-A1 | Odor neutralizers | SYMRISE AG (DE) | 2003-04-10 | — | — | US | disclosed |
| EP-1239890-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068295-A1 | Odor neutralizers | OXER1, OR51E2, OR10J3 | HCAR2 488/4885CA12 1769/4885AKR1B10 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.